Loading...
29–31 Aug orders dispatch 1 SeptRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed Treatments29–31 Aug orders dispatch 1 SeptRegistered Pharmacy100% OnlineFully Inspected & Regulated ServicesApproved UK-licensed Treatments
Dr Kyrollos Hanna
Medical Doctor & Health ADvisor
Our clinicians listen, guide, and help you make confident choices about your health at your pace. Every assessment is private, judgment-free, and reviewed by a qualified prescriber.
_Rectangle-1.png&w=1440&q=75)
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.
£99.00
_Rectangle.png&w=1440&q=75)
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.
£109.00
_Rectangle-1.png&w=1440&q=75)
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.
£129.00
_Rectangle.png&w=1440&q=75)
Wegovy pill contain semaglutide, a prescription-only medicine used for weight management in eligible adults. Taken once daily alongside a reduced-calorie diet and increased physical activity, Wegovy works on the GLP-1 pathway involved in appetite regulation.Once-daily oral pillContains semaglutide, a GLP-1 medicineAvailable in 1.5 mg, 4 mg, 9 mg and 25 mg strengthsTreatment begins at a lower dose and is increased gradually under clinical guidanceUsed alongside a reduced-calorie diet and increased physical activityPrescription-only and subject to clinician assessmentFor eligible adults aged 18 and overThe MHRA authorised Wegovy Pill for weight management in the UK on 11 June 2026. The approved strengths are 1.5 mg, 4 mg, 9 mg and 25 mg.
£187.00
-2.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£98.00
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£117.81
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£123.74
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£167.30
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£216.80
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£163.34
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£173.24
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£232.64
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£257.39
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£272.24
Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£292.04
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£99.00
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£110.00
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£125.00
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£140.00
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£165.00
Foundayo contains orforglipron, a prescription medicine used for weight management in eligible adults. It belongs to a group of medicines called GLP-1 receptor agonists and influences appetite regulation, which may help you eat less and reduce body weight.Foundayo is taken once daily alongside a reduced-calorie diet and increased physical activity, following an assessment by a qualified clinician. It can be taken at any time of day, with or without food.It is available in six strengths - 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg - so the dose can be increased gradually according to your response and how well you tolerate treatment.Contains orforglipronTaken once dailyNo injection requiredCan be taken with or without foodDose increased graduallyPrescription-only treatmentUsed alongside diet and physical activity
£180.00
